An active extract of Lindera obtusiloba inhibits adipogenesis via sustained Wnt signaling and exerts anti-inflammatory effects in the 3T3-L1 preadipocytes

Journal of Nutritional Biochemistry

Volumn 21, Issue 12, 2010, Pages 1170-1177

  Freise, Christian ^a   Erben, Ulrike ^a   Neuman, Ulf ^a   Kim, Kiyoung ^b   Zeitz, Martin ^a   Somasundaram, Rajan ^a   Ruehl, Martin ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Wonkwang University   (South Korea)

Author keywords

3T3 L1; Adipogenesis; Inflammation; Lindera obtusiloba

Indexed keywords

BETA CATENIN; CASPASE 3; CASPASE 7; GELATINASE A; GLUCOSE TRANSPORTER 4; INTERLEUKIN 6; LINDERA OBTUSILOBA EXTRACT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; WNT PROTEIN;

ADIPOGENESIS; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CYTOKINE RELEASE; DNA SYNTHESIS; ENZYME RELEASE; IC 50; LINDERA; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OBESITY; PROADIPOCYTE; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BETA CATENIN; CELL DIFFERENTIATION; CELL PROLIFERATION; DOWN-REGULATION; INFLAMMATION; INTERLEUKIN-6; LINDERA; MATRIX METALLOPROTEINASE 2; MICE; OBESITY; PHYTOTHERAPY; PLANT EXTRACTS; SIGNAL TRANSDUCTION; WNT PROTEINS;

LINDERA OBTUSILOBA;

EID: 78249235641     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.09.013     Document Type: Article

References (66)

1. Roth J., Qiang X., Marban S.L., Redelt H., Lowell B.C. The obesity pandemic: where have we been and where are we going?. Obes Res 2004, 12:88S-101S.
2. Prins J.B., O'Rahilly S. Regulation of adipose cell number in man. Clin Sci (Lond) 1997, 92:3-11.
3. Christiaens V., Scroyen I., Lijnen H.R. Role of proteolysis in development of murine adipose tissue. Thromb Haemost 2008, 99:290-294.
4. Nakajima I., Muroya S., Tanabe R., Chikuni K. Extracellular matrix development during differentiation into adipocytes with a unique increase in type V and VI collagen. Biol Cell 2002, 94:197-203.
5. Nakajima I., Yamaguchi T., Ozutsumi K., Aso H. Adipose tissue extracellular matrix: newly organized by adipocytes during differentiation. Differentiation 1998, 63:193-200.
6. Sorisky A., Gagnon A. Clinical implications of adipose tissue remodelling: adipogenesis and apoptosis. Can J Diabetes. 2002, 26:232-240.
7. Avram M.M., Avram A.S., James W.D. Subcutaneous fat in normal and diseased states 3. Adipogenesis: from stem cell to fat cell. J Am Acad Dermatol 2007, 56:472-492.
8. Rosen E.D., MacDougald O.A. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006, 7:885-896.
9. Schaffler A., Scholmerich J., Salzberger B. Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. Trends Immunol 2007, 28:393-399. [Epub 2007 Aug 2002].
10. Wellen K.E., Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003, 112:1785-1788.
11. Trayhurn P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 2005, 184:285-293.
12. Lin Y., Lee H., Berg A.H., Lisanti M.P., Shapiro L., Scherer P.E. The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J Biol Chem 2000, 275:24255-24263.
13. Sopasakis V.R., Sandqvist M., Gustafson B., Hammarstedt A., Schmelz M., Yang X., et al. High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obes Res 2004, 12:454-460.
14. Rotter V., Nagaev I., Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003, 278:45777-45784. [Epub 42003 Sep 45772].
15. Batterham R.L., Ffytche D.H., Rosenthal J.M., Zelaya F.O., Barker G.J., Withers D.J., et al. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 2007, 450:106-109. [Epub 2007 Oct 2014].
16. Christensen R., Kristensen P.K., Bartels E.M., Bliddal H., Astrup A. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 2007, 370:1706-1713.
17. Oh I.S., Shimizu H., Satoh T., Okada S., Adachi S., Inoue K., et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006, 443:709-712. [Epub 2006 Oct 2001].
18. Bachman E.S., Dhillon H., Zhang C.Y., Cinti S., Bianco A.C., Kobilka B.K., et al. betaAR signaling required for diet-induced thermogenesis and obesity resistance. Science 2002, 297:843-845.
19. Bjorbaek C., Kahn B.B. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 2004, 59:305-331.
20. Kushner R.F. Anti-obesity drugs. Expert Opin Pharmacother 2008, 9:1339-1350.
21. Beglinger C., Degen L. Gastrointestinal satiety signals in humans-physiologic roles for GLP-1 and PYY?. Physiol Behav 2006, 89:460-464. [Epub 2006 Jul 2007].
22. Kim H.K., Nelson-Dooley C., Della-Fera M.A., Yang J.Y., Zhang W., Duan J., et al. Genistein decreases food intake, body weight, and fat pad weight and causes adipose tissue apoptosis in ovariectomized female mice. J Nutr 2006, 136:409-414.
23. Lin J., Della-Fera M.A., Baile C.A. Green tea polyphenol epigallocatechin gallate inhibits adipogenesis and induces apoptosis in 3T3-L1 adipocytes. Obes Res 2005, 13:982-990.
24. Hargrave K.M., Meyer B.J., Li C., Azain M.J., Baile C.A., Miner J.L. Influence of dietary conjugated linoleic Acid and fat source on body fat and apoptosis in mice. Obes Res 2004, 12:1435-1444.
25. Rayalam S., Yang J.Y., Ambati S., Della-Fera M.A., Baile C.A. Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Phytother Res 2008, 7:7.
26. Yook C. Lindera obtusiloba. Medical Plants of Korea 1989, 184. Jinmyeong Publishing Co, Seoul. C.S. Yook (Ed.).
27. Kwon H.C., Baek N.I., Choi S.U., Lee K.R. New cytotoxic butanolides from Lindera obtusiloba BLUME. Chem Pharm Bull (Tokyo) 2000, 48:614-616.
28. Kwon H.C., Choi S.U., Lee J.O., Bae K.H., Zee O.P., Lee K.R. Two new lignans from Lindera obtusiloba blume. Arch Pharm Res 1999, 22:417-422.
29. Ruehl M., Erben U., Kim K., Freise C., Dagdelen T., Eisele S, et al. Extracts of Lindera obtusiloba induce antifibrotic effects in hepatic stellate cells via suppression of a TGF-beta-mediated profibrotic gene expression pattern. J Nutr Biochem 2008, 26:26.
30. Bertolani C., Marra F. The role of adipokines in liver fibrosis. Pathophysiology 2008, 3:3.
31. Ross S.E., Hemati N., Longo K.A., Bennett C.N., Lucas P.C., Erickson R.L., et al. Inhibition of adipogenesis by Wnt signaling. Science 2000, 289:950-953.
32. Croissandeau G., Chretien M., Mbikay M. Involvement of matrix metalloproteinases in the adipose conversion of 3T3-L1 preadipocytes. Biochem J 2002, 364:739-746.
33. Prins J.B., Walker N.I., Winterford C.M., Cameron D.P. Apoptosis of human adipocytes in vitro. Biochem Biophys Res Commun 1994, 201:500-507.
34. Qian H., Hausman D.B., Compton M.M., Martin R.J., Della-Fera M.A., Hartzell D.L., et al. TNFalpha induces and insulin inhibits caspase 3-dependent adipocyte apoptosis. Biochem Biophys Res Commun 2001, 284:1176-1183.
35. Rayalam S., Della-Fera M.A., Baile C.A. Phytochemicals and regulation of the adipocyte life cycle. J Nutr Biochem 2008, 19:19.
36. Hsu C.L., Yen G.C. Effects of capsaicin on induction of apoptosis and inhibition of adipogenesis in 3T3-L1 cells. J Agric Food Chem 2007, 55:1730-1736. [Epub 2007 Feb 1713].
37. Green H., Kehinde O. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 1975, 5:19-27.
38. Gregoire F.M., Smas C.M., Sul H.S. Understanding adipocyte differentiation. Physiol Rev 1998, 78:783-809.
39. Umek R.M., Friedman A.D., McKnight S.L. CCAAT- enhancer binding protein: a component of a differentiation switch. Science 1991, 251:288-292.
40. Della-Fera M.A., Qian H., Baile C.A. Adipocyte apoptosis in the regulation of body fat mass by leptin. Diabetes Obes Metab 2001, 3:299-310.
41. Magun R., Boone D.L., Tsang B.K., Sorisky A. The effect of adipocyte differentiation on the capacity of 3T3-L1 cells to undergo apoptosis in response to growth factor deprivation. Int J Obes Relat Metab Disord 1998, 22:567-571.
42. Geloen A., Roy P.E., Bukowiecki L.J. Regression of white adipose tissue in diabetic rats. Am J Physiol 1989, 257:E547-E553.
43. Yang J.Y., Della-Fera M.A., Hartzell D.L., Nelson-Dooley C., Hausman D.B., Baile C.A. Esculetin induces apoptosis and inhibits adipogenesis in 3T3-L1 cells. Obesity (Silver Spring) 2006, 14:1691-1699.
44. Yang J.Y., Della-Fera M.A., Rayalam S., Ambati S., Baile C.A. Enhanced pro-apoptotic and anti-adipogenic effects of genistein plus guggulsterone in 3T3-L1 adipocytes. Biofactors 2007, 30:159-169.
45. Rayalam S., Della-Fera M.A., Yang J.Y., Park H.J., Ambati S., Baile C.A. Resveratrol potentiates genistein's antiadipogenic and proapoptotic effects in 3T3-L1 adipocytes. J Nutr 2007, 137:2668-2673.
46. Fernyhough M.E., Okine E., Hausman G., Vierck J.L., Dodson M.V. PPARgamma and GLUT-4 expression as developmental regulators/markers for preadipocyte differentiation into an adipocyte. Domest Anim Endocrinol 2007, 33:367-378. [Epub 2007 May 2029].
47. Rea S., James D.E. Moving GLUT4: the biogenesis and trafficking of GLUT4 storage vesicles. Diabetes 1997, 46:1667-1677.
48. Miyazawa-Hoshimoto S., Takahashi K., Bujo H., Hashimoto N., Yagui K., Saito Y. Roles of degree of fat deposition and its localization on VEGF expression in adipocytes. Am J Physiol Endocrinol Metab 2005, 288:E1128-E1136. [Epub 2004 Dec 1121].
49. Liu J., Farmer S.R. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes. J Biol Chem 2004, 279:45020-45027. [Epub 42004 Aug 45010].
50. Logan C.Y., Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004, 20:781-810.
51. Bennett C.N., Ross S.E., Longo K.A., Bajnok L., Hemati N., Johnson K.W., et al. Regulation of Wnt signaling during adipogenesis. J Biol Chem 2002, 277:30998-31004. [Epub 32002 Jun 30997].
52. Moldes M., Zuo Y., Morrison R.F., Silva D., Park B.H., Liu J., et al. Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis. Biochem J 2003, 376:607-613.
53. Kawai M., Mushiake S., Bessho K., Murakami M., Namba N., Kokubu C., et al. Wnt/Lrp/beta-catenin signaling suppresses adipogenesis by inhibiting mutual activation of PPARgamma and C/EBPalpha. Biochem Biophys Res Commun 2007, 363:276-282. [Epub 2007 Aug 2027].
54. Aberle H., Bauer A., Stappert J., Kispert A., Kemler R. beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997, 16:3797-3804.
55. Amit S., Hatzubai A., Birman Y., Andersen J.S., Ben-Shushan E., Mann M., et al. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev 2002, 16:1066-1076.
56. Yanagawa S., Matsuda Y., Lee J.S., Matsubayashi H., Sese S., Kadowaki T., et al. Casein kinase I phosphorylates the Armadillo protein and induces its degradation in Drosophila. Embo J 2002, 21:1733-1742.
57. Christodoulides C., Lagathu C., Sethi J.K., Vidal-Puig A. Adipogenesis and WNT signalling. Trends Endocrinol Metab 2009, 20:16-24. [Epub 2008 Nov 2013].
58. Furuyashiki T., Nagayasu H., Aoki Y., Bessho H., Hashimoto T., Kanazawa K., et al. Tea catechin suppresses adipocyte differentiation accompanied by down-regulation of PPARgamma2 and C/EBPalpha in 3T3-L1 cells. Biosci Biotechnol Biochem 2004, 68:2353-2359.
59. Imai T., Takakuwa R., Marchand S., Dentz E., Bornert J.M., Messaddeq N., et al. Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse. Proc Natl Acad Sci U S A 2004, 101:4543-4547. [Epub 2004 Mar 4516].
60. Bouloumie A., Sengenes C., Portolan G., Galitzky J., Lafontan M. Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes 2001, 50:2080-2086.
61. Bourlier V., Zakaroff-Girard A., De Barros S., Pizzacalla C., de Saint Front V.D., Lafontan M., et al. Protease inhibitor treatments reveal specific involvement of matrix metalloproteinase-9 in human adipocyte differentiation. J Pharmacol Exp Ther 2005, 312:1272-1279. [Epub 2004 Nov 1210].
62. Maquoi E., Munaut C., Colige A., Collen D., Lijnen H.R. Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 2002, 51:1093-1101.
63. Kuppusamy U.R., Das N.P. Effects of flavonoids on cyclic AMP phosphodiesterase and lipid mobilization in rat adipocytes. Biochem Pharmacol 1992, 44:1307-1315.
64. Yang J.Y., Della-Fera M.A., Baile C.A. Guggulsterone inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 cells. Obesity (Silver Spring) 2008, 16:16-22.
65. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
66. Bastard J.P., Maachi M., Lagathu C., Kim M.J., Caron M., Vidal H., et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006, 17:4-12.